RTX News
RTX Corporation
$186.47
+$3.45(+1.89%)
61
Overall
90
Value
18
Tech
76
Quality
Market Cap
$246.67B
Volume
4.04M
52W Range
$155.64 - $226.88
Target Price
$227.76
RTX news: the latest RTX Corporation headlines, press releases and market updates, newest first.
Latest RTX News
- Bank of America Securities Reaffirms Their Buy Rating on Vertex Pharmaceuticals (VRTX)TipRanks Auto-Generated Intelligence Newsdesk · Oct 12, 2026
- Vertex and Moderna Advance CF mRNA Therapy: What VX-522 Trial Completion Means for InvestorsTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 9, 2026
- Vortex Energy Expands Saskatchewan Portfolio with Meadows Project AcquisitionTipRanks Canadian Auto-Generated Newsdesk · Oct 1, 2026
- Heron Therapeutics Expands U.S. Portfolio Through Licensing DealTipRanks Auto-Generated Newsdesk · Sep 29, 2026
- Analysts Are Bullish on Top Industrial Goods Stocks: Airbus Group SE (EADSF), RTX (RTX)TipRanks Newsroom · Sep 29, 2026
- Ex-Dividend Dates Nearing for These 10 Stocks – Week of September 28, 2026Gilan Miller-Gertz · Sep 27, 2026
- Ex-Dividend Dates Nearing for These 10 Stocks – Week of September 28, 2026Gilan Miller-Gertz · Sep 27, 2026
- Citi Keeps Their Buy Rating on Vertex Pharmaceuticals (VRTX)TipRanks Auto-Generated Intelligence Newsdesk · Sep 23, 2026
- Bernstein Sticks to Its Hold Rating for RTX (RTX)TipRanks Auto-Generated Intelligence Newsdesk · Sep 23, 2026
- Analysts Conflicted on These Healthcare Names: Pfizer (PFE), Celldex (CLDX) and Vertex Pharmaceuticals (VRTX)TipRanks Newsroom · Sep 23, 2026
- Surprise Greenland Deal Has Investors Looking in the Wrong PlaceTheStreet Pro · Sep 22, 2026
- Analysts Are Bullish on Top Healthcare Stocks: Vertex Pharmaceuticals (VRTX), Maze Therapeutics, Inc. (MAZE)TipRanks Newsroom · Sep 22, 2026
- 3 Defense Stocks with Recent Buy Ratings and More Than 20% UpsideSukanya Varma · Sep 21, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RTX | $186.47 | +1.9% | 4.04M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |